SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 24 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106 | -29.3% | 132 | 0.0% | 0.00% | – |
| Q2 2023 | $150 | -20.2% | 132 | +5.6% | 0.00% | – |
| Q1 2023 | $188 | +2.7% | 125 | +1.6% | 0.00% | – |
| Q4 2022 | $183 | – | 123 | +2.5% | 0.00% | – |
| Q3 2022 | $0 | – | 120 | +96.7% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 61 | -99.1% | 0.00% | – |
| Q1 2022 | $16,000 | -68.6% | 7,003 | -20.3% | 0.00% | – |
| Q4 2021 | $51,000 | +5000.0% | 8,783 | +14298.4% | 0.00% | – |
| Q3 2021 | $1,000 | -99.1% | 61 | -99.4% | 0.00% | – |
| Q2 2021 | $108,000 | +208.6% | 11,081 | +365.6% | 0.00% | – |
| Q1 2021 | $35,000 | – | 2,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Duquesne Family Office | 100,000 | $231,000 | 0.01% |
| FNY Investment Advisers, LLC | 3,500 | $8,000 | 0.01% |
| LEO BROKERAGE, LLC | 14,845 | $34,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 37,900 | $88,000 | 0.00% |
| UBS Group AG | 13,618 | $31,000 | 0.00% |
| RHUMBLINE ADVISERS | 16,169 | $37,000 | 0.00% |
| Ellevest, Inc. | 19 | $0 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 62,184 | $144,000 | 0.00% |
| FMR LLC | 179 | $0 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 10,375 | $24,000 | 0.00% |